Get the App
A

Anaptysbio (ANAB)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Anaptysbio (ANAB)

AnaptysBio, Inc. is a clinical stage biotechnology company. The Company is developing immunology therapeutic product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. It develops its ... Read more

  • USD25.03
  • USD25.72
  • USD23.89
  • USD32.96
  • -16.50%
  • 4M
  • 561.16k
  • 711M
  • 18.20
  • -22.30%

Stock News

3 Growth Stocks That Are Too Cheap to Ignore

1 hour ago

3 Growth Stocks That Are Too Cheap to Ignore

Yahoo

South African Ruling Party's Ties With Russia Pose Risks

1 hour ago

South African Ruling Party's Ties With Russia Pose Risks

Bloomberg

Outside the Box: Investments in a rut? Maybe it’s the Wall Street industrial complex.

1 hour ago

Outside the Box: Investments in a rut? Maybe it’s the Wall Street industrial complex.

MarketWatch

Tax Guy: My job is being eliminated and I will get a severance package. Is that considered income for IRS limits on Roth IRA contributions?

1 hour ago

Tax Guy: My job is being eliminated and I will get a severance package. Is that considered income for IRS limits on Roth IRA contributions?

MarketWatch

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium